The 2026 Wuzhen Health Conference, held from April 12 to 16 at the Wuzhen Internet International Convention and Exhibition Center, convened under the theme “Agility & Transformation: The Symphony of Tomorrow,” spotlighting pivotal shifts and emerging opportunities across China’s pharmaceutical sector. Among the event’s most prestigious honors, Zhejiang Zuoli Pharmaceutical Co., Ltd. received three major awards—recognizing leadership in industry innovation, marketing excellence, and cultural revitalization of traditional Chinese medicine (TCM).
Zuoli Pharmaceutical’s “Start from the Heart, Cultivate Blossoming Minds” campus-based mental health initiative was awarded the West Lake Award for Innovative Marketing. Launched in early 2025, the program responds directly to growing national concern over adolescent psychological well-being. Designed around the home-school partnership model, it delivers evidence-informed mental health seminars led by licensed physicians to students, parents, and educators across multiple provinces. By leveraging clinical expertise to address real-world psychosocial needs—and embedding that credibility within community-facing outreach—the initiative has strengthened public trust in Zuoli’s brand while demonstrating how purpose-driven engagement can yield measurable impact on both social outcomes and brand equity. The model is now being scaled as a replicable framework integrating clinical authority, educational infrastructure, and corporate social responsibility.
The company also earned third place in the TCM Cultural Creativity Competition’s “Golden Deer Award” (Cultural IP Category) for its “Sleep Super Symbol: Wuling IP.” Built around Zuoli’s flagship product, Wuling Capsules—a TCM formulation derived from Ophiocordyceps sinensis, a rare medicinal fungus colloquially known as the “panda of fungi”—the campaign reimagined the brand through a cohesive visual identity system. Central to the concept is the “closed-eye capsule” icon, merging the biological essence of Wuling with universally recognized pharmaceutical symbolism. Complemented by a distinctive blue-and-yellow color palette and consistent application across packaging, digital assets, and point-of-sale materials, the system elevates Wuling from a product name to an instantly recognizable cultural symbol. This strategic shift supports broader efforts to modernize TCM perception—making ancient therapeutic concepts accessible, relatable, and resonant with younger, digitally native consumers.
Mr. Wang Tao, General Manager of Zuoli Pharmaceutical, was honored with the West Lake Award for Outstanding Figure in China’s Pharmaceutical Industry. As architect of the company’s “C-First Strategy”—a consumer-centric transformation prioritizing patient experience, digital engagement, and value-based health outcomes—Mr. Wang has guided Zuoli through accelerated R&D investment, portfolio diversification, and IP-driven brand development. Under his leadership, core products have gained stronger market positioning, while the organization has deepened its integration of clinical insight, behavioral science, and creative communication.
Collectively, these accolades reflect broad industry recognition of Zuoli Pharmaceutical’s dual commitment: advancing scientific rigor in TCM research and development, and pioneering culturally intelligent approaches to health education and brand stewardship. Looking ahead, the company plans to expand its pipeline of clinically validated TCM interventions, deepen collaborations with academic and clinical institutions, and further embed social impact into its commercial strategy—all in service of China’s Healthy China 2030 initiative and the global evolution of integrative, person-centered healthcare.